David B. Cluck

486 total citations
35 papers, 296 citations indexed

About

David B. Cluck is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, David B. Cluck has authored 35 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 10 papers in Epidemiology and 8 papers in Pharmacology. Recurrent topics in David B. Cluck's work include Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). David B. Cluck is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). David B. Cluck collaborates with scholars based in United States. David B. Cluck's co-authors include Paul Lewis, Emily L. Heil, Jonathan P. Moorman, Justin M Spivey, Daniel B. Chastain, Eric F. Egelund, Melissa E. Badowski, John Williamson, Sam Harirforoosh and Amy L. Brotherton and has published in prestigious journals such as Infection Control and Hospital Epidemiology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.

In The Last Decade

David B. Cluck

30 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David B. Cluck United States 9 116 74 72 64 59 35 296
Janet Wu United States 8 97 0.8× 94 1.3× 91 1.3× 108 1.7× 40 0.7× 13 360
Dung Thi Khanh Khu Vietnam 10 64 0.6× 51 0.7× 66 0.9× 143 2.2× 69 1.2× 15 339
Timothy R. Pasquale United States 10 125 1.1× 39 0.5× 80 1.1× 28 0.4× 43 0.7× 16 282
Filippo Del Puente Italy 9 144 1.2× 89 1.2× 147 2.0× 99 1.5× 31 0.5× 32 349
C. K. Johnson United States 9 66 0.6× 95 1.3× 105 1.5× 91 1.4× 22 0.4× 12 389
Harry Schrager United States 6 224 1.9× 30 0.4× 117 1.6× 24 0.4× 45 0.8× 9 549
Takumi Umemura Japan 10 97 0.8× 56 0.8× 105 1.5× 34 0.5× 49 0.8× 41 273
Annelot F. Schoffelen Netherlands 10 187 1.6× 16 0.2× 112 1.6× 86 1.3× 31 0.5× 26 345
Mar Sánchez-Somolinos Spain 10 206 1.8× 38 0.5× 125 1.7× 15 0.2× 51 0.9× 18 345
Mary L. Townsend United States 12 192 1.7× 72 1.0× 159 2.2× 46 0.7× 34 0.6× 30 381

Countries citing papers authored by David B. Cluck

Since Specialization
Citations

This map shows the geographic impact of David B. Cluck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Cluck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Cluck more than expected).

Fields of papers citing papers by David B. Cluck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Cluck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Cluck. The network helps show where David B. Cluck may publish in the future.

Co-authorship network of co-authors of David B. Cluck

This figure shows the co-authorship network connecting the top 25 collaborators of David B. Cluck. A scholar is included among the top collaborators of David B. Cluck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David B. Cluck. David B. Cluck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
George, Mary G., et al.. (2025). The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategies. Therapeutic Advances in Infectious Disease. 12. 2038548657–2038548657. 6 indexed citations
3.
Chastain, Daniel B., et al.. (2025). Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review. Therapeutic Advances in Infectious Disease. 12. 2038578785–2038578785.
4.
5.
Chastain, Daniel B., et al.. (2024). Pivmecillinam for Uncomplicated Acute Cystitis: A Contemporary Review. Annals of Pharmacotherapy. 59(8). 743–757. 1 indexed citations
6.
Chastain, Daniel B., et al.. (2024). Managing Modern Antiretroviral Therapy in the Intensive Care Unit: Overcoming Challenges for Critically Ill People With Human Immunodeficiency Virus. Open Forum Infectious Diseases. 11(5). ofae213–ofae213. 2 indexed citations
7.
Sherman, Elizabeth M, Melanie R. Nicol, Daniel B. Chastain, et al.. (2023). Personalizing prevention: Advances in pharmacotherapy for HIV prevention. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(4). 305–320. 3 indexed citations
8.
Cluck, David B., et al.. (2023). Kimyrsa and Orbactiv – A Tale of Two Formulations. Drug Design Development and Therapy. Volume 17. 737–742. 2 indexed citations
9.
Chastain, Daniel B., et al.. (2023). Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy. Annals of Pharmacotherapy. 58(3). 305–321. 3 indexed citations
10.
Cluck, David B., Kayla R. Stover, Daniel B. Chastain, et al.. (2022). A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications for Hospitalized Patients in 2021. Open Forum Infectious Diseases. 9(12). ofac600–ofac600.
11.
Cluck, David B., et al.. (2019). HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study. Clinical Drug Investigation. 39(3). 285–299. 5 indexed citations
12.
Lewis, Paul, et al.. (2018). Failure of ceftolozane‐tazobactam salvage therapy in complicated pneumonia with lung abscess. Clinical Case Reports. 6(7). 1308–1312. 9 indexed citations
13.
Cluck, David B., et al.. (2018). Comparison of perceived personality traits between the pharmacy residents admitted through the match or scramble process. Currents in Pharmacy Teaching and Learning. 10(7). 834–841. 3 indexed citations
14.
Wrenn, Rebekah, David B. Cluck, LeAnne Kennedy, Christopher Ohl, & John Williamson. (2017). Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia. Journal of Oncology Pharmacy Practice. 24(3). 170–175. 20 indexed citations
15.
Cluck, David B., et al.. (2017). A Therapeutic Perspective of Living with Human Immunodeficiency Virus/AIDS in 2017. Nursing Clinics of North America. 53(1). 97–110. 5 indexed citations
16.
Lewis, Paul, et al.. (2017). Stability of a pyrimethamine suspension compounded from bulk powder. American Journal of Health-System Pharmacy. 74(24). 2060–2064. 4 indexed citations
17.
Cluck, David B., et al.. (2016). Using scientific inquiry to increase knowledge of vaccine theory and infectious diseases. Education for Health. 29(2). 95–95. 1 indexed citations
18.
Cluck, David B., et al.. (2016). Observations from the Phase II Match: Impact on Student Residency Candidates. American Journal of Pharmaceutical Education. 80(8). 144–144. 3 indexed citations
19.
Lu, Kevin, P. Brandon Bookstaver, Majdi N. Al‐Hasan, et al.. (2015). Evaluation of Empiric Therapy With Third-Generation Cephalosporins for Bloodstream Infections Secondary to Chromosomally-Mediated AmpC-Producing Enterobacteriaceae. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations
20.
Cluck, David B., et al.. (2012). Bacterial Contamination of an Automated Pharmacy Robot Used for Intravenous Medication Preparation. Infection Control and Hospital Epidemiology. 33(5). 517–520. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janet Wu Breakdown of academic impact, for papers by Dung Thi Khanh Khu Breakdown of academic impact, for papers by Timothy R. Pasquale Breakdown of academic impact, for papers by Filippo Del Puente Breakdown of academic impact, for papers by C. K. Johnson Breakdown of academic impact, for papers by Harry Schrager Breakdown of academic impact, for papers by Takumi Umemura Breakdown of academic impact, for papers by Annelot F. Schoffelen Breakdown of academic impact, for papers by Mar Sánchez-Somolinos Breakdown of academic impact, for papers by Mary L. Townsend
Rankless by CCL
2026